TICKERNOMICS Sign up
Last Update: 2023-10-04 11:36:55
IMARA Inc. ( IMRA ) https://imaratx.com
21.00USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
14.73%
IMRA
809.09%
SPY
36.71%
IMRA
11.17%
SPY
70.96%
IMRA
0.00%
SPY
262.36%
IMRA
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
863.23
571.70
0.10
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
615.28
0.00
2.96
-4.16
0.00
3.12
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.69
-102.23
-74.39
0.00
Other Earnings and Cash Flow Stats:
IMARA Inc. ( IMRA ) Net Income TTM ($MM) is -45.42
IMARA Inc. ( IMRA ) Operating Income TTM ($MM) is -47.43
IMARA Inc. ( IMRA ) Owners' Earnings Annual ($MM) is 0.00
IMARA Inc. ( IMRA ) Current Price to Owners' Earnings ratio is 0.00
IMARA Inc. ( IMRA ) EBITDA TTM ($MM) is 20.18
IMARA Inc. ( IMRA ) EBITDA Margin is 0.00%
Capital Allocation:
IMARA Inc. ( IMRA ) has paid 0.00 dividends per share and bought back -14.819013 million shares in the past 12 months
IMARA Inc. ( IMRA ) has reduced its debt by 1.907 million USD in the last 12 months
Capital Structure:
IMARA Inc. ( IMRA ) Interest-bearing Debt ($MM) as of last quarter is 0
IMARA Inc. ( IMRA ) Annual Working Capital Investments ($MM) are -11
IMARA Inc. ( IMRA ) Book Value ($MM) as of last quarter is 291
IMARA Inc. ( IMRA ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
IMARA Inc. ( IMRA ) has 292 million in cash on hand as of last quarter
IMARA Inc. ( IMRA ) has 10 million of liabilities due within 12 months, and long term debt 0 as of last quarter
IMARA Inc. ( IMRA ) has 41 common shares outstanding as of last quarter
IMARA Inc. ( IMRA ) has 0 million USD of preferred stock value
Academic Scores:
IMARA Inc. ( IMRA ) Altman Z-Score is 45.73 as of last quarter
IMARA Inc. ( IMRA ) Piotroski Score is 0.00 as of last quarter
Corporate Governance:
IMARA Inc. ( IMRA ) largest shareholder is Citadel Advisors Llc owning 776785 shares at 16.31 ($MM) value
Michael Gray(an insider) Sold 2464 shares of IMARA Inc. ( IMRA ) for the amount of $46027.52 on 2023-02-22
16.63% of IMARA Inc. ( IMRA ) is held by insiders, and 81.32% is held by institutions
IMARA Inc. ( IMRA ) went public on 2020-03-12
Other IMARA Inc. ( IMRA ) financial metrics:
FCF:-54.99
Unlevered Free Cash Flow:14.03
EPS:-8.93
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-20.21
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About IMARA Inc. ( IMRA ) :
IMARA Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapeutics to treat patients suffering from serious diseases. The company was incorporated in 2016 and is based in Brookline, Massachusetts.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.